Learning Objectives:

1: Outline the evidence supporting the link between the gut microbiome and cancer. 
2: Highlight novel therapeutic strategies to modulate the gut microbiome to optimize efficacy of PD-1 based immunotherapy

Session date: 
Thursday, April 8, 2021 - 8:00am to 9:00am
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Carolina Soto Chervin, MD, PhD